Skip to main content
. 2011 Nov 3;54(1):17–24. doi: 10.1093/cid/cir753

Figure 2.

Figure 2.

Cross-reactive neutralization activities to heterosubtypes of influenza viruses in serum samples of 2009 pandemic vaccine recipients. Neutralization activities against A/Moscow/10/1999(H3N2) (A), A/Brisbane/59/2007(H1N1) (B), A/Japan/305/57(H2N2) (C), and A/Viet Nam/1203/2004(H5N1) (D). Left, individual 50% inhibitory concentration (IC50) titers; middle, correlation between the hemagglutination-inhibition (HI) titers to pandemic influenza and IC50 titers to tested virus in sera postvaccination; right, correlation between the increase of HI titers to pandemic influenza from baseline and the change in magnitude of IC50 titers to tested virus.